Fraser MacDonald
Director/Board Member at PHARMALA BIOTECH HOLDINGS INC.
Net worth: 15 800 $ as of 29/04/2024
Profile
Fraser MacDonald is currently an Independent Director at Pharmala Biotech Holdings, Inc. and a Director at Pharmala Biotech, Inc. He completed his undergraduate degree at Queen's University and his graduate degree at Bond University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/02/2024 | 100,000 ( 0.12% ) | 15 800 $ | 29/04/2024 |
Fraser MacDonald active positions
| Companies | Position | Start |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director/Board Member | 20/03/2021 |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Director/Board Member | - |
Training of Fraser MacDonald
| Queen's University | Undergraduate Degree |
| Bond University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Fraser MacDonald
